Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non-Small-Cell Lung Cancer Patients

Bram L. T. Ramaekers*, Manuela A. Joore, Beranger Lueza, Julia Bonastre, Audrey Mauguen, Jean-Pierre Pignon, Cecile Le Pechoux, Dirk K. M. De Ruysscher, Janneke P. C. Grutters

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1295-1307
JournalJournal of Thoracic Oncology
Issue number10
Publication statusPublished - Oct 2013


  • Radiotherapy
  • Dose fractionation
  • Non-small-cell lung cancer
  • Cost-benefit analysis
  • Markov chain

Cite this